Depression, Bipolar
Information
- Disease name
- Depression, Bipolar
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00590265 | Active, not recruiting | N/A | Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression | January 2008 | June 2025 |
| NCT05211466 | Active, not recruiting | Digital Care Chains in Health Care - a Study of Care Consumption, Care Quality, Work Environment and Well-being | January 17, 2022 | November 1, 2025 | |
| NCT04640636 | Active, not recruiting | Phase 4 | IM Ketamine vs Midazolam for Suicidal ER Patients | January 2, 2021 | March 2025 |
| NCT03360942 | Active, not recruiting | Long Term Follow-up of Deep Brain Stimulation for Treatment-Resistant Depression | April 18, 2016 | November 22, 2028 | |
| NCT00483548 | Completed | Phase 3 | Adjunctive Ziprasidone in the Treatment of Bipolar I Depression | October 2007 | December 2008 |
| NCT00510146 | Completed | Phase 3 | Olanzapine Treatment of Patients With Bipolar I Disorder | August 2007 | July 2010 |
| NCT00608296 | Completed | Functional and Neurochemical Brain Changes Bipolar Depression | January 2008 | July 2013 | |
| NCT00621842 | Completed | Phase 3 | Lamotrigine for Symptoms of Geriatric Bipolar Depression | January 2008 | March 2010 |
| NCT00835107 | Completed | Phase 4 | An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression | February 2009 | June 2011 |
| NCT01303601 | Completed | Phase 4 | Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression | January 2009 | October 2010 |
| NCT01396447 | Completed | Phase 2 | Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression | July 26, 2011 | January 10, 2014 |
| NCT01898429 | Completed | N/A | Deep Brain Stimulation (DBS) for Treatment-Resistant Depression (TRD) | July 2013 | December 2016 |
| NCT02152878 | Completed | Phase 2/Phase 3 | Transcranial Direct Current Stimulation for the Treatment of Bipolar Depression | April 2014 | November 2016 |
| NCT00060489 | Completed | Phase 3 | Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression | September 2002 | September 2003 |
| NCT00186186 | Completed | Phase 4 | Depakote ER in Bipolar Depression | January 2004 | January 2009 |
| NCT00191399 | Completed | Phase 4 | Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response | May 2004 | March 2006 |
| NCT00422214 | Completed | Phase 3 | Phase III/Seroquel SR Bipolar Depression Monotherapy - US | December 2006 | June 2007 |
| NCT03287037 | Completed | N/A | The Effects of tDCS on Depressive Symptoms,Neurocognitive Function and HRV in Unipolar Depression and Bipolar Depression | October 2016 | September 6, 2019 |
| NCT03538275 | Completed | Chronobiology and Depression: Circadian Analytics as a Biomarker for Depressive Subtypes | March 13, 2018 | December 31, 2019 | |
| NCT04121091 | Completed | Phase 2 | Pramipexole to Target "Anhedonic Depression" | October 4, 2019 | March 18, 2021 |
| NCT04469322 | Completed | N/A | Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression | September 30, 2014 | June 26, 2018 |
| NCT04701866 | Completed | N/A | Music as an Intervention to Improve Hemodynamic Tolerability of Ketamine in Depression | January 11, 2021 | August 24, 2022 |
| NCT02827045 | Enrolling by invitation | Study of a Vestibular Biomarker of Phase in Bipolar Disorder | July 2016 | October 2024 | |
| NCT05568823 | Not yet recruiting | N/A | Biomarkers of ANTidepressant RESponse and Development Risk of Bipolar Disorder | November 1, 2022 | January 2, 2025 |
| NCT06462196 | Not yet recruiting | Natural History of Depression, Bipolar Disorder and Suicide Risk | June 23, 2024 | June 1, 2030 | |
| NCT06105762 | Not yet recruiting | N/A | Ketogenic Diet for Depression | January 1, 2024 | July 1, 2027 |
| NCT05958940 | Not yet recruiting | N/A | BioClock: Bright Light Therapy for Depressive Disorders | September 2023 | December 2025 |
| NCT04057378 | Recruiting | Phase 4 | Optimal Electrical Stimulus During Electroconvulsive Therapy | October 30, 2019 | November 15, 2025 |
| NCT02778256 | Recruiting | N/A | Study of the Effectiveness of Vestibular Stimulation Treatment in the Depressive Phase of Bipolar Disorder | June 2016 | October 30, 2024 |
| NCT02919280 | Recruiting | Dallas 2K: A Natural History Study of Depression | September 2016 | September 2026 | |
| NCT05767073 | Recruiting | N/A | LIVES: Personalized Lifestyle Intervention for Patients With Depression | September 1, 2020 | December 1, 2025 |
| NCT03423680 | Recruiting | Phase 3 | A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression | February 22, 2018 | November 2024 |
| NCT05913947 | Recruiting | Phase 4 | Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9) | December 13, 2022 | September 2024 |
| NCT05436613 | Recruiting | N/A | Transcranial Direct Current Stimulation Therapy for Bipolar Depression | May 1, 2022 | June 30, 2024 |
| NCT04846010 | Unknown status | Phase 1/Phase 2 | Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 | March 1, 2021 | October 1, 2022 |
| NCT04399070 | Unknown status | N/A | The Effect of S-ketamine for Patients Undergoing Electroconvulsive Therapy (ECT) | August 1, 2020 | January 31, 2021 |
| NCT04643210 | Unknown status | N/A | Management of my Bipolarity Intervention in Bipolar Disorder Patients | July 30, 2018 | December 31, 2022 |
| NCT02625779 | Withdrawn | Phase 2 | Combined Cytidine and Creatine-containing Drug in the Treatment of the Bipolar Depression | March 1, 2016 | April 30, 2017 |